Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness and Safety Study of Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

NCT01096511 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01096511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01096511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness and Safety Study of Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
January 31, 2011
Enrollment
1,001 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abscess, intra-abdominal, secondary peritonitis